This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: Mediterranean diet should be individualized, healthy dietary changes may reduce CVD risk
Among the top stories in cardiology last week were three presentations from the National Lipid Association Scientific Sessions that suggested that components of the Mediterranean diet can be individualized for goal attainment; early action and making healthy dietary changes may reduce risk for CVD in South Asian adults; and lipid abnormalities in South Asians may be related with coronary artery disease outcomes, diabetes and insulin resistance and may be associated with factors such as their smaller coronary artery diameter.
Other highlights included the FDA’s clearance of ControlRad’s radiation reduction technology for use during any fluoroscopic imaging procedure and the FDA’s issuance of an update on lower survival rate with a right heart pump system.
Components of Mediterranean diet can be individualized for goal attainment
MIAMI — The benefits of a Mediterranean diet have been shown in numerous studies, but more work must be done for patients to adopt it, according to a presentation at the National Lipid Association Scientific sessions. Read more.
Healthy dietary changes in South Asian adults may reduce CVD risk
MIAMI — The preparation of foods common in South Asian cuisines can increase the risk for CVD, but early action and substituting for healthier preparations may impact the risk, a speaker said. Read more.
South Asians have an increased risk for coronary heart disease events, diabetes
MIAMI — Lipid abnormalities in South Asians may be related with coronary artery disease outcomes, diabetes and insulin resistance and may be associated with factors such as their smaller coronary artery diameter, according to a speaker. Read more.
Technology to reduce radiation exposure during fluoroscopic procedures receives FDA clearance
ControlRad announced that its radiation reduction technology for use during any fluoroscopic imaging procedure such as atrial fibrillation ablation and percutaneous coronary intervention has been granted 510(k) clearance from the FDA. Read more.
FDA issues update on lower survival rate with right heart pump system
The FDA has updated a letter to health care providers about a lower survival rate with a temporary right heart pump system in patients from a postapproval study who would not have been eligible for the premarket clinical studies compared with the survival rate from the premarket clinical study. Read more.